Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Not applicable Interventional

Reducing Alcohol-Involved Suicidal Ideation and Behavior

ClinicalTrials.gov ID: NCT07946822

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07946822. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 3:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to learn whether a brief skills training can help people cope better with distress and reduce suicidal thoughts and behaviors that happen along with alcohol use. The study looks at this both in a lab and in everyday life. It is for adults ages 21 to 54 who currently have thoughts of suicide and who engage in heavy episodic drinking (drinking a large amount of alcohol on a single occasion; specifically, 4 drinks in 2 hours for females and 5 drinks in 2 hours for males). The main questions it aims to answer are: * Can two coping skills from Dialectical Behavior Therapy (paced breathing and expanding awareness) reduce distress, suicidal thoughts, and urges to self-harm while a person has been drinking alcohol? * Can text messages sent during the two weeks after the lab visit help people who drink alcohol have fewer suicidal thoughts and behaviors, compared with getting no text messages?

Study identification

NCT ID
NCT07946822
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Georgia State University
Other
Enrollment
240 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years to 54 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2027 (Estimated)
Primary completion
Jun 2031 (Estimated)
Completion
Jun 2031 (Estimated)
Last update posted
Nov 18, 2026

2027 – 2031

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Georgia State University Atlanta Georgia 30303 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07946822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.